Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service colorectal resection cases in Kentucky: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 4% on average (227 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 5 | 1,219 | 37% |
| 2020 | 1 | 986 | 41% |
| 2021 | 1 | 936 | 47% |
Laparoscopic and open colectomy and proctectomy; stapler, energy, and robotics call point. Professional codes (what the surgeon bills): CPT 44204, 44205, 44207, 44140, 44145, 44160, 45395, 45397; the hospital bills MS-DRG 329, 330, 331.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in Kentucky; 1 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cholecystectomy & appendectomy | 56 | 2,482−8.2%/yr | −8.2%/yr | 5.61.3× | 1% | 2,450 in 2030−0.2%/yr |
| Hernia repair |
Colorectal resection in every state, and its device makers · Every procedure market in Kentucky · Every state · Compare with Florida
| 2024 |
| 780 |
| 57% |
| 2025 est. | ≈ 670 | – |
| 2026 est. | ≈ 670 | – |
| 2022 | 2 | 829 | 52% |
| 2023 | 2 | 873 | 55% |
| 2024 | 1 | 780 | 57% |
| 2025 from claims | – | 667 545–787 | 58% |
| 2026 forecast | – | 665 528–842 | 59% |
| 2027 forecast | – | 665 501–888 | 60% |
| 2028 forecast | – | 665 479–928 | 60% |
| 2029 forecast | – | 664 460–964 | 61% |
| 2030 forecast | – | 664 444–998 | 62% |
In 2025, 100% inpatient hospital.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
| −5.4%/yr |
| 1.6 |
| 0% |
| 3,550 in 2030+1.1%/yr |
| North Carolina | 8 | 1,522−6.8%/yr | −6.8%/yr | 1.6 | 0% | 1,300 in 2030−2.6%/yr |
| Virginia | 8 | 1,407−5%/yr | −5%/yr | 1.4 | 0% | 1,380 in 2030−0.3%/yr |
| Georgia | 9 | 1,394−6.4%/yr | −6.4%/yr | 1.7 | 0% | 1,360 in 2030−0.4%/yr |
| Tennessee | 8 | 1,188−5.9%/yr | −5.9%/yr | 1.7 | 0% | 1,160 in 2030−0.4%/yr |
| Maryland | 9 | 1,056−3.7%/yr | −3.7%/yr | 1.2 | 0% | 1,190 in 2030+2.1%/yr |
| South Carolina | 6 | 1,039−5%/yr | −5%/yr | 1.5 | 0% | 1,130 in 2030+1.5%/yr |
| Oklahoma | 7 | 801−4.5%/yr | −4.5%/yr | 1.7 | 0% | 680 in 2030−2.7%/yr |
| Alabama | 7 | 736−8.8%/yr | −8.8%/yr | 1.7 | 0% | 720 in 2030−0.3%/yr |
| Louisiana | 3 | 664−8%/yr | −8%/yr | 1.7 | 0% | 600 in 2030−1.6%/yr |
| Mississippi | 5 | 658−8.2%/yr | −8.2%/yr | 1.8 | 0% | 630 in 2030−0.7%/yr |
| Arkansas | 3 | 639−6%/yr | −6%/yr | 1.7 | 0% | 630 in 2030−0.3%/yr |
| West Virginia | 0 | 250−9.7%/yr | −9.7%/yr | 1.2 | 0% | 190 in 2030−4.7%/yr |
| Delaware | 2 | 243−5.8%/yr | −5.8%/yr | 1.4 | 0% | 310 in 2030+4.1%/yr |
| District of Columbia | 1 | 194−5.2%/yr | −5.2%/yr | 3.1 | 0% | 170 in 2030−2.1%/yr |
| 20 |
| 2,350−6.8%/yr |
| −6.8%/yr |
| 5.50.9× |
| 1% |
| 2,370 in 2030+0.1%/yr |
| Antireflux & hiatal hernia surgery | 6 | 347−6.8%/yr | −6.8%/yr | 0.81.0× | 0% | 360 in 2030+0.8%/yr |
| Breast reconstruction | 1 | 150−4.6%/yr | −4.6%/yr | 0.30.7× | 0% | 110 in 2030−4.6%/yr |
| Bariatric surgery | 1 | 101−21%/yr | −21%/yr | 0.21.3× | 0% | 70 in 2030−5.1%/yr |
Intuitive Surgical leads with 81% of company spending on these surgeons in 2025, −8 pts on 2024.
In 2025, 3 companies reported engagement with Kentucky’s surgeons worth $122K in consulting, speaking, meals and travel tied to these products, about $122K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 14 clearances and approvals in the category, 12 recalled product lines (1 Class I). A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.